Screener
Haemonetics HAE UNITED STATES — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
FAQ
- What is Haemonetics's UNITED STATES — revenue?
- Haemonetics (HAE) reported UNITED STATES — revenue of $257.84M in Q2 2026.
- How has Haemonetics's UNITED STATES — revenue changed year-over-year?
- Haemonetics's UNITED STATES — revenue increased by 6.4% year-over-year, from $242.4M to $257.84M.
- What does UNITED STATES — revenue mean?
- This metric represents the total net sales generated from products and services provided to customers located within the United States, excluding any sales-related taxes collected on behalf of government authorities. It serves as a primary indicator of the company's market penetration and commercial performance within the domestic healthcare sector. Tracking this revenue stream helps investors assess the company's ability to capitalize on regional demand for blood and plasma collection technologies and hospital-based medical solutions.
Ask your AI about Haemonetics's united states — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude